$3.02
Lexaria Bioscience, a Kelowna, Canada-based company that develops drug delivery platforms, is seeking a listing on the Nasdaq. The company is currently listed on the Over-the-Counter Markets under the ticker "LXRP," as well as the Canadian Securities Exchange under the ticker symbol "LXX."
Our top picks for where to buy Lexaria Bioscience stock
How to buy Lexaria Bioscience Corp stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LEXX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Lexaria Bioscience Corp stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Lexaria Bioscience Corp stock price (NASDAQ: LEXX)
Use our graph to track the performance of LEXX stocks over time.Lexaria Bioscience Corp shares at a glance
Latest market close | $3.02 |
---|---|
52-week range | $0.76 - $6.85 |
50-day moving average | $3.08 |
200-day moving average | $2.32 |
Wall St. target price | $10.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.44 |
Is it a good time to buy Lexaria Bioscience Corp stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lexaria Bioscience Corp price performance over time
Historical closes compared with the close of $3.02 from 2024-07-23
1 week (2024-07-17) | 4.86% |
---|---|
1 month (2024-06-24) | 13.96% |
3 months (2024-04-24) | 37.27% |
6 months (2024-01-24) | 92.36% |
1 year (2023-07-24) | 255.29% |
---|---|
2 years (2022-07-22) | 7.86% |
3 years (2021-07-23) | 6.77 |
5 years (2019-07-24) | 23.1 |
Lexaria Bioscience Corp financials
Revenue TTM | $411,019 |
---|---|
Gross profit TTM | $183,556 |
Return on assets TTM | -38.21% |
Return on equity TTM | -70.66% |
Profit margin | 0% |
Book value | $0.64 |
Market Capitalization | $43.2 million |
TTM: trailing 12 months
Lexaria Bioscience Corp share dividends
We're not expecting Lexaria Bioscience Corp to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (5.65% forward annual dividend yield)
Have Lexaria Bioscience Corp's shares ever split?
Lexaria Bioscience Corp's shares were split on a 1:30 basis on 11 January 2021. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lexaria Bioscience Corp shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Lexaria Bioscience Corp shares which in turn could have impacted Lexaria Bioscience Corp's share price.
Lexaria Bioscience Corp share price volatility
Over the last 12 months, Lexaria Bioscience Corp's shares have ranged in value from as little as $0.7598 up to $6.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lexaria Bioscience Corp's is 1.023. This would suggest that Lexaria Bioscience Corp's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Lexaria Bioscience Corp's beta into context you can compare it against those of similar companies.
- Pfizer (PFE.US): 0.634
- Moderna (MRNA.US): 1.662
- BioNTech (BNTX.US): 0.233
Lexaria Bioscience Corp overview
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Frequently asked questions
nullWhat percentage of Lexaria Bioscience Corp is owned by insiders or institutions?
Currently 10.407% of Lexaria Bioscience Corp shares are held by insiders and 5.703% by institutions. How many people work for Lexaria Bioscience Corp?
Latest data suggests 5 work at Lexaria Bioscience Corp. When does the fiscal year end for Lexaria Bioscience Corp?
Lexaria Bioscience Corp's fiscal year ends in August. Where is Lexaria Bioscience Corp based?
Lexaria Bioscience Corp's address is: 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7 What is Lexaria Bioscience Corp's ISIN number?
Lexaria Bioscience Corp's international securities identification number is: US52886N4060
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question